指南与共识糖尿病

糖尿病患者连续酮体监测:新技术应用的国际专家建议

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.
指南 / 共识 · Lancet Diabetes Endocrinol · 2026-01-01

连续酮体监测(CKM)有望降低糖尿病患者糖尿病酮症酸中毒(DKA)风险,但缺乏明确阈值。国际DKA管理专家组成专家组,基于客观实用原则制定CKM应用建议,获国际儿童青少年糖尿病学会(ISPAD)认可,旨在指导CKM安全有效使用并避免警报疲劳。

要点

  • CKM可预警病日DKA高风险并预测未来DKA总体风险。
  • 需建立明确酮体阈值以指导CKM用户采取行动。
  • 阈值设定应避免可避免的焦虑和警报疲劳。

核心结论

  • CKM技术有望降低DKA风险,但需明确酮体阈值和行动建议以确保安全有效。

研究设计与样本

  • 国际DKA管理专家组成专家组制定客观实用的CKM应用建议,获ISPAD认可。

主要发现

  • CKM数据可在病日警报急性DKA高风险,并基于日常酮体分布预测未来DKA风险。
  • 正常血糖DKA发生率增加,使CKM成为糖尿病管理工具包的重要补充。

关键数值与推荐

  • 国际临床指南已基于即时检测建立疑似和确诊DKA的酮体阈值,作为高血糖和酸中毒三联标志物的一部分。
  • 正常血糖DKA的葡萄糖浓度低于既定诊断阈值。

临床怎么用

  • CKM用户应根据明确酮体阈值采取行动,阈值设定需平衡预警效果与避免焦虑和警报疲劳。

局限性

  • 缺乏大量证据确定CKM使用的合适酮体阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ability to reduce the risk of developing diabetic ketoacidosis (DKA) remains a major care gap for people with diabetes, particularly those on intensive insulin therapy. The anticipated availability of continuous ketone monitoring (CKM) has the potential to reduce the risk of developing DKA, one of the most life-threatening acute complications of type 1 and type 2 diabetes. International clinical guidelines have established ketone thresholds for suspected and confirmed diagnoses of DKA, based on use of point-of-care testing, as part of a triad of markers with allied thresholds for hyperglycaemia and acidosis. The increasing occurrence of euglycemic DKA, with glucose concentrations below established diagnostic thresholds, makes the availability and use of CKM technology an important addition to the diabetes management toolkit. CKM data could alert the user when the risk of acute DKA is high on sick days in addition to signalling that individuals might be predicted to be at greater overall risk of future DKA on the basis of the distribution and degree of ketone measures in daily life. If widespread use of CKM devices is to be safe and effective in reducing the occurrence of DKA, it is important to establish clear ketone thresholds which notify CKM users when action on their part is required. In defining these thresholds and actions, it was important to ensure that the CKM user is not exposed to avoidable anxiety or suffers alarm fatigue, thus adding to the burden of living with diabetes. In the absence of substantial evidence that can identify appropriate ketone thresholds for CKM use, a panel of international experts in the management of DKA was convened with the aim of developing a number of objective, practical recommendations on how this novel diabetes technology could improve outcomes for individuals at risk of DKA, the results of which we report in this Personal View. These recommendations have been endorsed by the International Society for Pediatric and Adolescent Diabetes (ISPAD).

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Dhatariya K, Bergenstal RM, Al-Sofiani M, et al. Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology. Lancet Diabetes Endocrinol. 2026. PMID: 41381175. doi:10.1016/S2213-8587(25)00331-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。